Pathology
For Treatment of Odontogenic Keratocysts, Is Enucleation, When Compared to Decompression, a Less Complex Management Protocol?

https://doi.org/10.1016/j.joms.2014.11.001Get rights and content

Purpose

To determine whether the clinical management of odontogenic keratocysts (OKCs) is more complex in patients who undergo enucleation with or without adjuvant therapy than in patients who undergo decompression with or without residual cystectomy.

Materials and Methods

The authors implemented a retrospective cohort study and enrolled a sample composed of patients presenting for the evaluation and management of OKCs. The predictor variable was treatment group, classified as decompression with or without residual cystectomy versus enucleation with or without adjuvant therapy (Carnoy solution, cryotherapy, or peripheral ostectomy). The outcome variables were measurements of complexity of management, including total number of procedures, venue of procedure (operating room vs office), type of anesthesia, hospital admissions, and total number of follow-up visits. Data analyses were performed using univariate and bivariate statistics and a multiple linear regression model.

Results

The study sample was composed of 45 patients (66 OKC lesions) with a mean age of 43.3 years. Of the 66 OKCs treated, 34 (51.5%) were treated with decompression with or without residual cystectomy and 32 (48.5%) were treated with enucleation with or without adjunctive therapy. Larger lesions and lesions with radiographic evidence of cortical perforation were treated more often with decompression with or without residual cystectomy. Based on the multiple linear regression model, patients who underwent enucleation with or without adjuvant therapy compared with those who underwent decompression with or without residual cystectomy had on average 1) 1.1 fewer total procedures (P < .01), 2) 0.8 fewer total office procedures (P < .01), 3) 0.6 fewer local anesthesia procedures (P < .01), and 4) 4.8 fewer postoperative visits (P < .01). There was no difference in the number of general anesthesia procedures, office sedation procedures, or hospital admissions.

Conclusion

Given comparable recurrence rates, the increased complexity of managing OKCs with decompression with or without residual cystectomy might not be warranted. Enucleation with or without adjunctive therapy could be the more efficient treatment option.

Section snippets

Study Design and Sample

To address research objectives, the authors designed and implemented a retrospective cohort study. The study cohort was derived from the population of patients presenting to the Department of Oral and Maxillofacial Surgery at the Massachusetts General Hospital (Boston, MA) from February 2001 to April 2011 for the evaluation and management of keratocyst odontogenic tumors. The study was reviewed and approved by the Partners Healthcare Human Studies investigational review board (Massachusetts

Results

During the study interval, 46 patients with 69 OKCs were evaluated and treated at the study institution. One patient was excluded from the sample because of a diagnosis of nevoid basal cell carcinoma syndrome. The final sample was composed of 45 patients with 66 lesions (Table 1). The sample's mean age was 43.3 ± 21.9 years and 57.8% were men. Twenty patients (44.4%) had ASA status I and 25 (55.6%) had an ASA status of least II. Thirty-one (47.0%) lesions were previously untreated and 35

Discussion

Although many studies have compared the recurrence rates for the 2 treatments, no study to date has analyzed the differences in management complexity for enucleation with or without adjuvant therapy versus decompression with or without residual cystectomy. The purpose of this study was to analyze the management complexity for treatment of OKCs with enucleation with or without adjuvant therapy compared with decompression with or without residual cystectomy. The authors tested the null hypothesis

References (34)

  • P.J.W. Stoelinga

    Long-term follow-up on keratocysts treated according to a defined protocol

    Int J Oral Maxillofac Surg

    (2001)
  • R. Chuong et al.

    The odontogenic keratocyst

    J Oral Maxillofac Surg

    (1982)
  • G.H. Irvine et al.

    Mandibular keratocysts: Surgical management

    Br J Oral Maxillofac Surg

    (1985)
  • M. Partridge et al.

    The primordial cyst (odontogenic keratocyst): Its tumour-like characteristics and behavior

    Br J Oral Maxillofac Surg

    (1987)
  • J. Jensen et al.

    A comparative study of treatment of keratocysts by enucleation or enucleation combined with cryotherapy. A preliminary report

    J Craniomaxillofac Surg

    (1988)
  • R.A. Voorsmit et al.

    The management of keratocysts

    J Maxillofac Surg

    (1981)
  • P.J.W. Stoelinga et al.

    The incidence, multiple presentation and recurrence of aggressive cysts of the jaws

    J Craniomaxillofac Surg

    (1988)
  • Cited by (15)

    • How reliable are follow-up studies on odontogenic keratocysts?

      2023, International Journal of Oral and Maxillofacial Surgery
    • Precise locating and cutting of the bone lid with a digital template during the treatment of large mandibular cysts: A case series study

      2021, Journal of Cranio-Maxillofacial Surgery
      Citation Excerpt :

      The molar region of the mandible was a high-risk area, followed by the anterior region of the maxilla (Tamiolakis et al., 2019). Enucleation is the most commonly used surgical procedure because the cyst can be removed entirely to reduce recurrence, and postoperative care is easy to perform (Kinard et al., 2015). However, there is a disadvantage in that the lateral bone must be removed during the operation to gain access and expose the cyst clearly (Pappalardo and Guarnieri, 2014).

    • How well do we manage the odontogenic keratocyst? A multicenter study

      2019, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
    • Triangular radiolucent lesion of the mandible

      2016, Journal of the American Dental Association
      Citation Excerpt :

      However, if the lesion is resected, the recurrence rate can be virtually zero.2,4,6 Treatment remains a controversial topic because there are no randomized controlled experiments in the literature but generally ranges from simple enucleation with or without the use of adjunctive treatment (Carnoy solution, cryotherapy, or peripheral ostectomy) to more aggressive surgical resection.4,7,8 However, for larger mandibular lesions, especially with vital structures at risk of injury, decompression might be the preferred therapy.8

    View all citing articles on Scopus

    This project was supported in part by the Massachusetts General Hospital Department of Oral and Maxillofacial Surgery Education and Research Fund (to B.E.K.), the Center for Applied Clinical Investigation (to S.-K.C. and T.B.D.), and the Massachusetts General Physicians Organization (to S.-K.C, M.A., and T.B.D.).

    Conflict of Interest Disclosures: Dr. Dodson is a consultant to AAOMS. None of the other authors reported any disclosures.

    View full text